Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsLymphocytesGraft vs Host DiseaseTransplantation, AutologousTissue DonorsWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalBusulfanHistocompatibility TestingBone Marrow PurgingHistocompatibilityHematopoietic Stem CellsLymphocyte ActivationTransplantation, IsogeneicCyclophosphamideKidney TransplantationT-LymphocytesBone Marrow DiseasesMice, Inbred C57BLHematopoiesisRecurrenceRadiation ChimeraCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressive AgentsGraft RejectionTime FactorsLeukemia, Myeloid, AcuteBone Marrow ExaminationLymphocyte DepletionTreatment OutcomeHematologic NeoplasmsRemission InductionTransplantation ImmunologyGraft vs Host ReactionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseImmunosuppressionBone RemodelingBone Marrow NeoplasmsLeukemia, MyeloidLiving DonorsHeart TransplantationLymphocyte TransfusionLeukocyte TransfusionAcute DiseaseStem Cell TransplantationLymphoma, Non-HodgkinHLA AntigensSevere Combined ImmunodeficiencyChimeraSpleenLeukocyte CountColony-Forming Units AssaySurvival AnalysisRetrospective StudiesMyelodysplastic SyndromesLung TransplantationFlow CytometryCells, CulturedCyclosporineMice, Inbred BALB CBlood DonorsHematologic DiseasesActuarial AnalysisCell DifferentiationBone DensityLymphocyte CountB-LymphocytesOrgan TransplantationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsGraft vs Tumor EffectLymphocyte SubsetsCarmustineFollow-Up StudiesPancytopeniaCytomegalovirus InfectionsGraft vs Leukemia EffectSurvival RateCytarabineLymphomaGranulocyte Colony-Stimulating FactorImmunophenotypingBone ResorptionAntibodies, MonoclonalThymus GlandMelphalanDisease-Free SurvivalMice, Knockout